glp-1 drugs addiction Weight-Loss Could Address a Range of Addictions GLP-1 weight-loss treatment is being

Glucagon-like peptide-1 (GLP-1) medications like semaglutide and tirzepatide, with brands such as Ozempic and Mounjaro, designed for diabetes, and Wegovy and Zepbound, designed for weight loss, have been soaring in popularity due to their effectiveness as weight loss aids

Postulated direct renoprotective effects of GLP-1 receptor agonists: preclinical evidence In order to define the intrakidney mode of action of GLP-1 receptor agonists, numerous preclinical studies have been performed, predominantly, but not exclusively, in models of DKD

Methods This post hoc analysis assessed the HbA1c-lowering efficacy of semaglutide, a GLP-1RA, in participants with a range of kidney functions in the SUSTAIN 46 and 10 (subcutaneous semaglutide) and PIONEER 5 and 6 (oral semaglutide) clinical trials

About 40% of American adults are clinically obese, with a BMI of 30 or higher, according to the Centers for Disease Control and Prevention

In fact on the figure above those who have lost 5% of their initial body weight were already heavier after a year than they were at baseline, and those in 5%-10% bracket were back at their baseline weight

The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets